Registered entities
Lycia Therapeutics, Inc.
Reg. No. 84-3860514United States
Innovation
17 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 683 times.
| Year | Filings |
|---|---|
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 13 |
| 2026 | 5 |
Social engagement
Social engagement: 6.7K social following, 3 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Versant Ventures, Venrock.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Private equity | 1 | 10% |
| Other / undisclosed | 6 | 60% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
31 Jan 2026 · Associate Director/Director, Clinical Science · South San Francisco
Based on job postings tracked across public sources.
Recent activity
25 Jun 2026
Leadership hire
Chief Financial Officer